loadpatents
name:-0.016260147094727
name:-0.011703014373779
name:-0.00053215026855469
THORENS; Bernard Patent Filings

THORENS; Bernard

Patent Applications and Registrations

Patent applications and USPTO patent grants for THORENS; Bernard.The latest application filed is for "use of vgii3 activity modulator for the modulation of adipogenesis".

Company Profile
0.11.11
  • THORENS; Bernard - Epalinges CH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use Of Vgii3 Activity Modulator For The Modulation Of Adipogenesis
App 20150065563 - HALL; Diana ;   et al.
2015-03-05
Use Of Inhibitors Of Zdhhc2 Activity For Modulation Of Adipogenesis
App 20150057334 - HALL; Diana ;   et al.
2015-02-26
Use of Vgll3 activity modulator for the modulation of adipogenesis
Grant 8,852,939 - Hall , et al. October 7, 2
2014-10-07
Use of inhibitors of Zdhhc2 activity for modulation of adipogenesis
Grant 8,841,270 - Hall , et al. September 23, 2
2014-09-23
Transiently Immortalized Cells For Use In Gene Therapy
App 20140178965 - Baetge; E. Edward ;   et al.
2014-06-26
Use of siRNA targetting SIPA1L1 for the reduction of adipogenesis
Grant 8,759,311 - Hall , et al. June 24, 2
2014-06-24
Use Of Sirna Targetting Sipa1l1 For The Reduction Of Adipogenesis
App 20130018083 - Hall; Diana ;   et al.
2013-01-17
Use Of Inhibitors Of Zdhhc2 Activity For Modulation Of Adipogenesis
App 20120165391 - Hall; Diana ;   et al.
2012-06-28
Use Of Vgii3 Activity Modulator For The Modulation Of Adipogenesis
App 20120101150 - Hall; Diana ;   et al.
2012-04-26
Use Of Inhibitors Of Plac8 Activity For The Modulation Of Adipogenesis
App 20120035241 - Hall; Diana ;   et al.
2012-02-09
Transiently Immortalized Cells For Use In Gene Therapy
App 20080064102 - Baetge; E. Edward ;   et al.
2008-03-13
Transiently immortalized cells for use in gene therapy
Grant 6,451,601 - Baetge , et al. September 17, 2
2002-09-17
Transiently immortalized cells for use in gene therapy
App 20020076787 - Baetge, Edward E. ;   et al.
2002-06-20
Transiently immortalized cells
Grant 6,358,739 - Baetge , et al. March 19, 2
2002-03-19
Methods And Compositions For Producing Cells Resistant To Apoptosis
App 20010006949 - THORENS, BERNARD ;   et al.
2001-07-05
Receptor for the glucagon-like-peptide (GLP-1)
Grant 6,051,689 - Thorens April 18, 2
2000-04-18
Method for detecting glucagon-like peptide-1 antagonists and agonists
Grant 5,846,747 - Thorens , et al. December 8, 1
1998-12-08
Mammalian receptors for glucagon-like-peptide-1 (GLP-1), corresponding DNA and recombinant expression systems, and screening assays for GLP-1 agonists and enhancers
Grant 5,670,360 - Thorens September 23, 1
1997-09-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed